上海招聘

Responsibilities: ? Leading a group of scientist and be responsible for the humanization and optimization of antibody candidates generated by hybridoma- or phage display-technology. ? Managing the group and taking responsibility for its projects by driving and coordinating his/her direct reports in achieving the specific objectives of the respective research projects. ? Representing the Biologics department in specific antibody project teams. ? Taking responsibility for defining project requirements, identifying potential issues, and providing solutions to resolve the issues. Qualifications: ? The ideal candidate will have a Ph.D. with 5+ years experience (or MS with 10+ years experience) in molecular biology, biochemistry, biotechnology or biological sciences ? This individual will be a highly motivated scientist with a proven track record in antibody engineering, preferably with post-doctoral experience in an academic or industry setting (for Ph.D. level candidate). ? A strong background in molecular biology, with extensive experience in antibody engineering, antibody expression and purification, and biochemical and biophysical methods for the analysis of antibodies is required. ? Familiarity with antibody biology, phage display technology, and affinity maturation, and interpretation of computational modeling of antibody-antigen interactions would be useful. Further, experience in preclinical development of therapeutic antibodies is desirable but not required. ? Strong communication skills, both oral and written, in Chinese and English. ? The incumbent will be required to focus on multiple issues at one time, and must have the ability to organize and direct diverse activities in a changing environment, often under time pressure. ? With a mature, self-confident and well-balanced personality, it is essential that the candidate also possess a high standard of ethical and intellectual integrity.

上海睿智化学研究有限公司成立于2002年，是一家世界领先的科研外包服务机构(CRO)，秉承着创新驱动、客户至上的服务理念，致力于为全球制药公司和生物技术公司提供全面且高品质的新药研发服务。
公司业务涵盖了抗体早期研发、小分子早期研发、药理药效、药代药动及早期毒理、生物药CMC、化药CMC、临床样品生产等新药研发各环节，为客户提供整合一体化的新药研发外包服务，已经服务过的国内外制药企业和生物医药技术公司1000余家，其中包括全球排名前20位的医药和生物技术企业。

公司在全球设立了6个办事处，专职研发人员2000人，海归科学家150人，拥有大规模最先进的科研、办公设施、实验动物设施、cGMP级别的公斤级实验室以及医药中间体生产设施。公司通过坐落于张江、奉贤、启东、成都和南旧金山五个重要研发基地持续不断为来自全球范围内客户长期提供优质的服务。